CASP3 and neoplasm: As expected, combined therapy increased apoptosis and reduced tumor cell proliferation, as determined by immunostaining for cleaved caspase-3 (CC3) and Ki67 (Fig. 5c) and Western blot analysis of CC3 (Fig. 5d).